s'authentifier
version française rss feed
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
Tixier F., Le Rest C. C., Hatt M., Albarghach N. M., Pradier O., Metges J.-P., Corcos L., Visvikis D.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 52, 3 (2011) 369-78 - http://www.hal.inserm.fr/inserm-00574272
(21321270)
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.
Florent Tixier () 1, Catherine Cheze Le Rest1, 2, Mathieu Hatt1, Nidal Albarghach1, 3, Olivier Pradier1, 3, Jean-Philippe Metges3, Laurent Corcos4, Dimitris Visvikis1
1 :  LATIM - Laboratoire de Traitement de l'Information Medicale
INSERM : U650 – Université de Bretagne Occidentale [UBO] – Institut Mines-Télécom – Télécom Bretagne – CHU Brest – PRES Université Européenne de Bretagne [UEB]
Hopital Morvan, 5 Avenue Foch, 29609 Brest Cedex
France
2 :  Médecine nucléaire
CHU Brest – Hôpital Morvan
Brest
France
3 :  Institut de cancérologie et d'hématologie
CHU Brest – Hôpital Morvan
Brest
France
4 :  Génétique moléculaire et génétique épidémiologique
INSERM : U613 – Université de Bretagne Occidentale [UBO]
Etablissement Francais du Sang 46, Rue Felix Le Dantec 29220 Brest Cedex 2
France
UNLABELLED: (18)F-FDG PET is often used in clinical routine for diagnosis, staging, and response to therapy assessment or prediction. The standardized uptake value (SUV) in the primary or regional area is the most common quantitative measurement derived from PET images used for those purposes. The aim of this study was to propose and evaluate new parameters obtained by textural analysis of baseline PET scans for the prediction of therapy response in esophageal cancer. METHODS: Forty-one patients with newly diagnosed esophageal cancer treated with combined radiochemotherapy were included in this study. All patients underwent pretreatment whole-body (18)F-FDG PET. Patients were treated with radiotherapy and alkylatinlike agents (5-fluorouracil-cisplatin or 5-fluorouracil-carboplatin). Patients were classified as nonresponders (progressive or stable disease), partial responders, or complete responders according to the Response Evaluation Criteria in Solid Tumors. Different image-derived indices obtained from the pretreatment PET tumor images were considered. These included usual indices such as maximum SUV, peak SUV, and mean SUV and a total of 38 features (such as entropy, size, and magnitude of local and global heterogeneous and homogeneous tumor regions) extracted from the 5 different textures considered. The capacity of each parameter to classify patients with respect to response to therapy was assessed using the Kruskal-Wallis test (P < 0.05). Specificity and sensitivity (including 95% confidence intervals) for each of the studied parameters were derived using receiver-operating-characteristic curves. RESULTS: Relationships between pairs of voxels, characterizing local tumor metabolic nonuniformities, were able to significantly differentiate all 3 patient groups (P < 0.0006). Regional measures of tumor characteristics, such as size of nonuniform metabolic regions and corresponding intensity nonuniformities within these regions, were also significant factors for prediction of response to therapy (P = 0.0002). Receiver-operating-characteristic curve analysis showed that tumor textural analysis can provide nonresponder, partial-responder, and complete-responder patient identification with higher sensitivity (76%-92%) than any SUV measurement. CONCLUSION: Textural features of tumor metabolic distribution extracted from baseline (18)F-FDG PET images allow for the best stratification of esophageal carcinoma patients in the context of therapy-response prediction.
Sciences du Vivant/Ingénierie biomédicale/Médecine nucléaire
Anglais
1535-5667

Articles dans des revues avec comité de lecture
10.2967/jnumed.110.082404
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
internationale
03/2011
14/02/2011
52
3
369-78

Aged – Aged – 80 and over – Antineoplastic Combined Chemotherapy Protocols – Carboplatin – Cisplatin – Combined Modality Therapy – Esophageal Neoplasms – Female – Fluorodeoxyglucose F18 – Fluorouracil – Humans – Image Enhancement – Image Interpretation – Computer-Assisted – Male – Middle Aged – Positron-Emission Tomography – Prognosis – Radiopharmaceuticals – Radiotherapy – Conformal – Reproducibility of Results – Sensitivity and Specificity – Treatment Outcome
Liste des fichiers attachés à ce document : 
PDF
texture_for_HAL.pdf(669.4 KB)

tous les articles de la base du CCSd...